Wen-Han Chang, MS

  • 6Articles
  • 30.2KReads
  • 2018–2025Active
  • 21Collaborators
  • 96Citations

About

Wen-Han Chang, MS, is affiliated with the Department of Psychiatry at Taipei Veterans General Hospital in Taipei, Taiwan. Chang has published extensively on topics including child and adolescent psychiatry, dementia, neurology, suicide, Alzheimer disease, bipolar disorder, and major depressive disorder. Research contributions include studies on mortality risks in psychiatric populations, familial aggregation of bipolar disorders, cognitive impairment related to polypharmacy, and metabolic risks in attention-deficit/hyperactivity disorder. Chang’s work appears in Psychiatrist.com from 2018 through 2025.

Publications

JCP
Parental Severe Mental Disorders and Deaths in Offspring With MDD
Original Research

Parental Severe Mental Disorders and Deaths in Offspring With MDD

March 31, 2025

Parental-Severe-Mental-Disorder-All-Cause-Suicide-Mortalities-Adolescent-Young-Adults-Major-Depressive-Disorder
, , , et al
JCP
Excess Mortality Associated With Schizophrenia
Original Research

Excess Mortality Associated With Schizophrenia

September 13, 2023

Females, patients with connective tissue disorders, and those aged 20 years or younger were especially impacted by the effect of schizophrenia on increasing mortality.
, , , et al
JCP
Original Research

Coaggregation of BD-I/BD-II With Major Psychiatric Disorders

September 7, 2021

Etiologic differences between bipolar I and II disorders have been challenged recently. This study used a large nationwide database to determine the risk of familial aggregation of specific psychiatric...
, , , et al
JCP
Original Research

Mortality Prediction Model for Dementia Patients

June 11, 2019

Using an 11-year follow-up of a population-based retrospective cohort, a risk score model identified 11 acute and chronic factors to predict mortality for dementia patients. A suitable care plan...
, , , et al
JCP
Original Research

Polypharmacy and Cognitive Impairment and Capacity

September 25, 2018

Polypharmacy has been shown to be associated with dementia, though its relationship to mild cognitive impairment (MCI), often a precursor to dementia, has received less study. Read this article...
, , , et al
JCP
Original Research

ADHD and Type 2 Diabetes Mellitus

May 1, 2018

Anecdotal evidence suggests that risk factors related to type 2 diabetes mellitus—including obesity, hypertension, and dyslipidemia—may be associated with attention-deficit/hyperactivity disorder. This study looked at this possible relationship more...
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe